Primary hyperoxaluria: Simultaneous combined liver and kidney transplantation from a living related donor

Creative Commons License

Astarcioglu I., Karademir S., Gulay H., Bora S., Astarcioglu H., Kavukcu S., ...Daha Fazla

LIVER TRANSPLANTATION, cilt.9, sa.4, ss.433-436, 2003 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 9 Sayı: 4
  • Basım Tarihi: 2003
  • Doi Numarası: 10.1053/jlts.2003.50072
  • Dergi Adı: LIVER TRANSPLANTATION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.433-436
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Primary hyperoxaluria type 1 (PH1) is a rare inherited metabolic disorder in which deficiency of the liver enzyme AGT leads to renal failure and systemic oxalosis. Timely, combined cadaveric liver-kidney transplantation (LKT) is recommended for end-stage renal failure (ESRF) caused by PHI; however, the shortage of cadaveric organs has generated enthusiasm for living-related transplantation in years. Recently, successful sequential LKT from the same living donor has been reported in a child with PHI. We present a sister-to-brother simultaneous LKT in a pediatric patient who suffered from PHI with ESRF. Twelve months after transplantation, his daily urine oxalate excretion was decreased from 160 mg to 19.5 mg with normal liver and renal allograft functions. In addition to the well-known advantages of living organ transplantation, simultaneous LKT may facilitate early postoperative hemodynamic stability and may induce immunotolerance and allow for low-dose immunosuppression.